ADCT
ADC Therapeutics·NYSE
--
--(--)
--
--(--)
ADCT Filings
Filing Date
Form Description
Form Type
2026-04-02
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-04-02 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-03-17
Form EFFECT - Notice of Effectiveness
2026-03-17 ·
Form EFFECT - Notice of Effectiveness
2026-03-16
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-03-16 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-03-10
ADC Therapeutics SA (ADCT) Q4 2025 Earnings Call Transcript
Earnings Call
2026-03-10 · Earnings Call
ADC Therapeutics SA (ADCT) Q4 2025 Earnings Call Transcript
2026-03-10
Form S-3 - Registration statement under Securities Act of 1933
2026-03-10 ·
Form S-3 - Registration statement under Securities Act of 1933
2026-03-10
Form ARS - Annual Report to Security Holders
2026-03-10 ·
Form ARS - Annual Report to Security Holders
2026-03-10
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Financials
2026-03-10 · Financials
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026-03-10
Form 8-K - Current report
Key Events
2026-03-10 · Key Events
Form 8-K - Current report
2026-02-23
Form 8-K - Current report
Key Events
2026-02-23 · Key Events
Form 8-K - Current report
2026-02-18
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-02-18 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
